Company Filing History:
Years Active: 2016-2018
Title: The Innovative Contributions of Neil W. Gibson in Metabolic Research
Introduction
Neil W. Gibson, an accomplished inventor based in San Diego, CA, has made significant strides in the field of metabolic disorders through his innovative research. With a total of three patents to his name, Gibson's work emphasizes the potential of modified oligonucleotides in treating various diseases.
Latest Patents
Gibson's latest patents focus on the therapeutic targeting of microRNAs to address metabolic disorders. He describes compounds that comprise modified oligonucleotides that are complementary to miR-103 and/or miR-107. These advancements present new methods for treating diseases and disorders linked to these crucial microRNAs.
Career Highlights
Throughout his career, Neil W. Gibson has been associated with Regulus Therapeutics Inc., a company that specializes in developing innovative RNA-targeted medicines. His work has not only contributed to advancing existing medical treatments but also paved the way for new approaches in molecular medicine.
Collaborations
Gibson collaborates with esteemed professionals in his field, including Balkrishen Bhat and Diedre MacKenna. These partnerships foster an environment of shared knowledge, enhancing research outcomes and driving innovative solutions in metabolic health.
Conclusion
Neil W. Gibson's contributions to the field of metabolic disorders showcase the impact of innovative inventions on healthcare. Through his patents and collaborations at Regulus Therapeutics Inc., Gibson continues to push the boundaries of scientific research, aiming to improve treatment modalities for metabolic conditions.